MARKET

HCM

HCM

Hutchmed (China) Limited
NASDAQ
15.90
+0.48
+3.08%
Opening 13:19 07/08 EDT
OPEN
15.70
PREV CLOSE
15.42
HIGH
15.95
LOW
15.69
VOLUME
12.97K
TURNOVER
--
52 WEEK HIGH
21.50
52 WEEK LOW
11.51
MARKET CAP
2.77B
P/E (TTM)
73.55
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HCM last week (0630-0704)?
Weekly Report · 1d ago
HUTCHMED Breaks Above 200-Day Moving Average - Bullish for HCM
NASDAQ · 4d ago
HUTCHMED to Announce 2025 Half-Year Financial Results
Barchart · 5d ago
Weekly Report: what happened at HCM last week (0623-0627)?
Weekly Report · 06/30 09:26
Hutchmed announces approval of NDA for Orpathys, Tagrisso combination in China
TipRanks · 06/30 09:10
HUTCHMED Receives China NMPA Approval For ORPATHYS In Combination With TAGRISSO For Treatment Of EGFRm NSCLC Patients With MET Amplification After Progression On EGFR Inhibitor Therapy
Benzinga · 06/30 08:53
HUTCHMED ANNOUNCES CHINA APPROVAL FOR ORPATHYS® IN COMBINATION WITH TAGRISSO® FOR THE TREATMENT OF LUNG CANCER PATIENTS WITH MET AMPLIFICATION AFTER PROGRESSION ON FIRST-LINE EGFR INHIBITOR THERAPY
Reuters · 06/30 08:30
Weekly Report: what happened at HCM last week (0616-0620)?
Weekly Report · 06/23 09:25
More
About HCM
HUTCHMED (China) Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.

Webull offers HUTCHMED (China) Ltd (ADR) stock information, including NASDAQ: HCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HCM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HCM stock methods without spending real money on the virtual paper trading platform.